SEC 13F Intelligence

Consonance Capital Management LP / GNMK

Consonance Capital Management LP’s Genmark Diagnostics Inc Position

Does Consonance Capital Management LP own Genmark Diagnostics Inc (GNMK)? Not currently — the last reported position was 4.48M shares worth $65M in Q4 2020; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$65M
Q4 2020
Shares
4.48M
% of Portfolio
+6.11%
Quarters Held
3
position exited

Position History GNMK

Reported value by quarter
Q2 ’20: $101MQ2 ’20Q3 ’20: $75MQ3 ’20Q4 ’20: $65MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20204.48M$65M+6.11%
Q3 20205.30M$75M+9.17%
Q2 20206.89M$101M+6.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of GNMK.